| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Crizotinib | CCLE | pan-cancer | AAC | -0.008 | 0.9 |
| mRNA | BRD-K33514849 | CTRPv2 | pan-cancer | AAC | 0.023 | 0.9 |
| mRNA | NSC 74859 | CTRPv2 | pan-cancer | AAC | -0.0066 | 0.9 |
| mRNA | pac-1 | GDSC1000 | pan-cancer | AAC | 0.0062 | 0.9 |
| mRNA | QL-VIII-58 | GDSC1000 | pan-cancer | AAC | 0.0079 | 0.9 |
| mRNA | AMG-706 | GDSC1000 | pan-cancer | AAC | 0.0059 | 0.9 |
| mRNA | Vandetanib | FIMM | pan-cancer | AAC | -0.031 | 0.9 |
| mRNA | Bosutinib | CTRPv2 | pan-cancer | AAC | -0.0057 | 0.9 |
| mRNA | ML210 | CTRPv2 | pan-cancer | AAC | -0.0051 | 0.9 |
| mRNA | vorapaxar | CTRPv2 | pan-cancer | AAC | -0.0058 | 0.9 |